Last edition
News about "acute coronary syndrome (ACS) "
CureGene Doses First Patient in Pivotal US Trial of Evategrel
CureGene achieves first participant dosed in US pivotal trial for Evategrel (CG-0255), a best-in-class antiplatelet drug, accelerating global commercialisation.
Acute Coronary Syndrome (ACS) | 23/06/2026 | By News Bureau | 193
Alembic Pharmaceuticals Secures USFDA Approval for Ticagrelor Tablets, 60 mg
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ticagrelor Tablets, 60 mg. The product is therapeutically equivalent to Brilinta Tablets, 60 mg, from AstraZeneca.
Acute Coronary Syndrome (ACS) | 29/10/2025 | By Dineshwori | 309
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy